Wendy Rogers is Professor of Clinical Ethics at Macquarie University. She is co-chair of the Safety, Quality and Ethics program of the Australian Alliance on AI in Healthcare, and a founding member of the International Network on the Future of AI and Medical Ethics (INFAIME). She has worked in bioethics for over 25 years, leading research on topics including the ethics of surgical innovation, voluntary and forced organ donation, the role of vulnerability in clinical and research ethics, and overdiagnosis. Prof Rogers is currently leading the revision of the Australian human research ethics guidelines, and received the 2019 NHMRC ethics award for her services to ethics guidance and policy in Australia.
Jack joined the Brighton Business School from the University of Westminster where he had taught and completed his PhD in Moral Philosophy and Reproductive Medicine. He is currently the module leader of the LLB Law of Torts, Healthcare Law and Ethics, and Legal Research Project modules. He has recently had articles published on Rights Theory ( 7(3) Laws 28), Legal Moralism ( 8(1) Laws 6), and Gender Deception in Sexual Offences ( Journal of Criminal Law doi: 10.1177/0022018319834373). He is editing a collection of essays with Claire-Michelle Smyth and Richard Lang entitled Contemporary Challenges to Human Rights Law due to be published in late 2019.
Dr. Craig Purshouse is a Lecturer in Law at the University of Leeds. His research interests are in torts law and medical law. He is a member of the Editorial Board of the Medical Law Review and his research has been cited by the Court of Appeal of Singapore and the United Kingdom Supreme Court.
A significant part of Dr Flear’s work has focused on reframing governance and regulation beyond the state on public health, and as part of that new technologies, as a field for biopolitics. In this work he argues that citizen participation would add a valuable input of knowledge on health inequalities and vulnerabilities to shape the trajectory of innovation and improve the efficacy, accountability and legitimacy of public health regulation as a whole. Dr Flear pioneered ‘European law and new health technologies’ as a field and collaborative network and provided the first map of the modes of European Union law as it engages with new technologies. Research funding, clinical trials, pharmaceuticals, medical devices, patents and health indicators are some of the most important examples Dr Flear examines throughout his work. His research brings together insights from law, regulatory studies, critical theory, science and technology studies (STS) and the social studies of science, and his sustained engagement with these disciplines has informed each of his research projects.
Lecturer in Global Health, St Georges University of London
Honorary Lecturer, Institute for Global Health, University College London
She specialises in transcultural psychiatry with a focus on mental health and gender-based violence during conflict and humanitarian crisis with a focus on cross-cultural notions of trauma. She is the Co-investigator on an MRC/AHRC funded 2-year project called Story-Telling for Health: Acknowledgement, Expression, and Recovery (SHAER) bringing together collaborators from Kashmir, Afghanistan, Turkey, Tunisia, and South Africa. Her work also includes providing expert reports for asylum seeker cases. She has published widely in academic journals and national and international media outlets as well as speaking at conference and public events worldwide. Her book Humanitarian Action and Ethics co-edited with James Smith was published in 2018 (Zed Publishers).
Doctor in Law (University of Buenos Aires)
Professor of Regulation of Biotechnology at the University of Buenos Aires and Patent Law at FLACSO (Latin American University of Social Sciences).
Chair of the Advisory Commission on Advanced Therapies at the Ministry of Science, Technology and Innovative Production and Ministry of Health of Argentina.
Additionally, Fabiana has been an advisor to the Science and Technology Commission (formed by the Chamber of Deputies of the Argentinean Parliament) and advisor to the REDBIO Foundation on Intellectual Property Issues (formed by Redbio/FAO).
She combines her academic activities with her work as intellectual property and patent lawyer, having a particular specialty and experience in international trade law, intellectual property rights and regulations associated with biotechnology and health law. She has worked for a multinational seeds and biotechnological company and in her role as Global Intellectual Property Manager she managed regulatory issues and a patent and trademarks portfolio in more than 45 countries.
Fabiana is currently undertaking ambitious research on the field of regulation of new technologies in health. She promoted the creation of RED APTA, (Argentinean Network of Patients’ Associations for Advanced Therapies). In 2014 he founded ACTYON Foundation, an NGO devoted to promote research and new technologies accessibility in the field of health. She combines and synergises her role as an associate professor to the Mason Institute and Innogen Research Foundation, University of Edinburgh.